Published in Crit Care Med on March 01, 2003
Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev (2006) 1.99
Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol (2008) 1.68
Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med (2006) 1.57
Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care (2006) 1.41
Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.40
Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India (2012) 1.40
Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia. Crit Care (2008) 1.32
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care (2011) 1.31
Antibiotic stewardship in the intensive care unit. Crit Care (2014) 1.18
Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 1.16
Relationship between feeding tube site and respiratory outcomes. JPEN J Parenter Enteral Nutr (2011) 1.04
Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance. Eur J Clin Microbiol Infect Dis (2008) 1.02
Intensive care unit-acquired Stenotrophomonas maltophilia: incidence, risk factors, and outcome. Crit Care (2006) 1.02
Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care (2012) 1.00
From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment. Crit Care (2016) 0.93
Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia. J Clin Microbiol (2014) 0.91
Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia. Eur J Clin Microbiol Infect Dis (2014) 0.90
Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One (2012) 0.89
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in patients with acute respiratory distress syndrome and abdominal diseases: a preliminary observational study. Crit Care (2011) 0.89
Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PLoS One (2012) 0.85
Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies. Respir Care (2013) 0.84
Continuous versus intermittent administration of piperacillin-tazobactam in intensive care unit patients with ventilator-associated pneumonia. Indian J Crit Care Med (2012) 0.84
Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779]. Crit Care (2006) 0.83
Ventilator-Associated Pneumonia: When to hold the breath? Int J Crit Illn Inj Sci (2013) 0.82
Gram-negative infections in adult intensive care units of latin america and the Caribbean. Crit Care Res Pract (2014) 0.79
CD8⁺ T-cell counts: an early predictor of risk and mortality in critically ill immunocompromised patients with invasive pulmonary aspergillosis. Crit Care (2013) 0.79
Identifying missed opportunities to curtail antimicrobial therapy for presumed ventilator-associated pneumonia using the clinical pulmonary infection score. Can J Hosp Pharm (2009) 0.79
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis (2014) 0.78
A biomarker panel (Bioscore) incorporating monocytic surface and soluble TREM-1 has high discriminative value for ventilator-associated pneumonia: a prospective observational study. PLoS One (2014) 0.77
Viral-Reactivated Pneumonia during Mechanical Ventilation: Is There Need for Antiviral Treatment? Front Pharmacol (2011) 0.77
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators. Crit Care (2010) 0.77
Treatment of ventilator-associated pneumonia: get it right from the start. Crit Care Med (2003) 0.77
Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome. Crit Care (2015) 0.76
Effects of proton pump inhibitors on lung cancer precise radiotherapy-induced radiation pneumonitis. Cell Biochem Biophys (2014) 0.76
World-wide variation in incidence of Acinetobacter associated ventilator associated pneumonia: a meta-regression. BMC Infect Dis (2016) 0.75
Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis. Ann Intensive Care (2016) 0.75
Alcohol-based hand rub and ventilator-associated pneumonia after elective neurosurgery: An interventional study. Indian J Crit Care Med (2011) 0.75
Nosocomial pneumonia in the intensive care unit: how should treatment failure be predicted? Rev Bras Ter Intensiva (2014) 0.75
Biomarker kinetics in the prediction of VAP diagnosis: results from the BioVAP study. Ann Intensive Care (2016) 0.75
Duration of antibiotic therapy in the intensive care unit. J Thorac Dis (2016) 0.75
The best of respiratory infections from the 2015 European Respiratory Society International Congress. ERJ Open Res (2016) 0.75
Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis. Eur J Clin Microbiol Infect Dis (2016) 0.75
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Evolution of mechanical ventilation in response to clinical research. Am J Respir Crit Care Med (2007) 3.45
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med (2013) 2.95
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy. Clin Infect Dis (2013) 2.30
Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Med (2014) 2.18
Is a strategy based on routine endotracheal cultures the best way to prescribe antibiotics in ventilator-associated pneumonia? Chest (2013) 2.15
Characteristics and outcomes of ventilated patients according to time to liberation from mechanical ventilation. Am J Respir Crit Care Med (2011) 2.15
Impact of sedation and analgesia during noninvasive positive pressure ventilation on outcome: a marginal structural model causal analysis. Intensive Care Med (2015) 2.11
Incidence, risk factors and outcome of barotrauma in mechanically ventilated patients. Intensive Care Med (2004) 1.96
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest (2006) 1.84
Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis (2009) 1.80
Pneumonia severity index class v patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores. Chest (2007) 1.77
Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa. Crit Care Med (2014) 1.77
Management and outcome of mechanically ventilated neurologic patients. Crit Care Med (2011) 1.71
Reexamining quinolone use in the intensive care unit: use them right or lose the fight against resistant bacteria. Crit Care Med (2005) 1.71
Nosocomial pneumonia in the intensive care unit: controversies and dilemmas. J Intensive Care Med (2004) 1.61
Hyponatremia in community-acquired pneumonia. Am J Nephrol (2007) 1.59
Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock (2010) 1.54
Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med (2013) 1.48
[Argentine consensus of non-invasive ventilation]. Medicina (B Aires) (2005) 1.37
Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care (2006) 1.33
Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med (2002) 1.27
Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest (2002) 1.27
Outcome of reintubated patients after scheduled extubation. J Crit Care (2011) 1.23
Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis (2009) 1.21
Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol (2007) 1.16
Who should receive antibiotics for exacerbations of chronic bronchitis? A plea for more outcome-based studies. Clin Infect Dis (2004) 1.10
Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med (2013) 1.09
Community-acquired pneumonia: an unfinished battle. Med Clin North Am (2011) 1.09
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. Clin Infect Dis (2008) 1.06
Diagnosis and treatment of rhinovirus respiratory infections. Chest (2003) 1.00
Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis (2010) 0.98
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia. J Antimicrob Chemother (2004) 0.97
Prognostic role of clinical and laboratory criteria to identify early ventilator-associated pneumonia in brain injury. Chest (2008) 0.96
Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation. J Crit Care (2005) 0.96
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia. Arch Intern Med (2007) 0.94
An analysis of 332 fatalities infected with pandemic 2009 influenza A (H1N1) in Argentina. PLoS One (2012) 0.93
A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia. Chest (2005) 0.93
Nosocomial pneumonia: lessons learned. Crit Care Clin (2013) 0.91
Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock (2005) 0.91
Pulmonary infections and resistance to antibiotics: recent information. Expert Rev Anti Infect Ther (2012) 0.91
Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions. Chest (2002) 0.90
Airway pressure release ventilation versus assist-control ventilation: a comparative propensity score and international cohort study. Intensive Care Med (2010) 0.90
An assessment of the Acute Kidney Injury Network creatinine-based criteria in patients submitted to mechanical ventilation. Clin J Am Soc Nephrol (2011) 0.88
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome. Respirology (2013) 0.87
Community-Acquired Pneumonia Recovery in the Elderly (CAPRIE): efficacy and safety of moxifloxacin therapy versus that of levofloxacin therapy. Clin Infect Dis (2005) 0.87
Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia. Crit Care Med (2003) 0.85
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents (2013) 0.85
Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma. J Am Med Dir Assoc (2010) 0.84
Clinical issues and research in respiratory failure from severe acute respiratory syndrome. Am J Respir Crit Care Med (2004) 0.83
Year in review 2013: Critical Care--respiratory infections. Crit Care (2014) 0.83
Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. Treat Respir Med (2004) 0.83
Health-care-associated pneumonia: a new therapeutic paradigm. Chest (2005) 0.83
What is the natural history of resolution of nosocomial pneumonia? Semin Respir Crit Care Med (2002) 0.82
Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia? Infect Dis Clin North Am (2012) 0.81
Viral community-acquired pneumonia: if we do not diagnose it and do not treat it, can it still hurt us? Chest (2010) 0.80
Pneumonia complicating pregnancy. Clin Chest Med (2010) 0.80
Nosocomial pneumonia. Curr Opin Infect Dis (2002) 0.80
How do we optimize outcomes for patients with severe community-acquired pneumonia? Intensive Care Med (2002) 0.79
Acid-base patterns in acute severe asthma. J Asthma (2013) 0.79
Predicting mortality in the elderly with community-acquired pneumonia: should we design a new car or set a new 'speed limit'? Thorax (2010) 0.78
Standardized care for nosocomial pneumonia is a valuable tool to improve patient outcomes: how do we get intensivists to listen? Crit Care Med (2009) 0.78
Understanding the natural history of community-acquired pneumonia resolution: vital information for optimizing duration of therapy. Clin Infect Dis (2004) 0.78
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia. Chest (2002) 0.77
Treatment of hospital-acquired pneumonia. Lancet Infect Dis (2011) 0.77
What is next in sepsis: current trials in sepsis. Expert Rev Anti Infect Ther (2012) 0.77
Improving outcomes in community-acquired pneumonia. Curr Opin Pulm Med (2016) 0.77
Granulocyte colony-stimulating factor for severe pneumonia: what do we do when the best laid plans for men (and mice and rats...) fail? Crit Care Med (2003) 0.77
Improving quality in the intensive care unit setting. Crit Care Clin (2006) 0.77
Inhaled corticosteroids and systemic inflammatory response in community-acquired pneumonia: a prospective clinical study. Respirology (2014) 0.77
Update in respiratory infections 2011. Am J Respir Crit Care Med (2012) 0.76
A rare case of respiratory disorders associated with two autosomal recessive diseases and male infertility. Allergy Rhinol (Providence) (2013) 0.76
[Maternal morbidity and perinatal mortality in HELLP syndrome. Multicentric studies in intensive care units in Buenos Aires area]. Medicina (B Aires) (2005) 0.76
Workshop on clinical trials of antibacterial agents for hospital-acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis (2010) 0.76
Therapy of ventilator-associated pneumonia: what more can we do to use less antibiotics? Crit Care Med (2004) 0.76
Antimicrobial therapy of community-acquired pneumonia. Infect Dis Clin North Am (2004) 0.76
Road ahead to respiratory health: experts chart future research directions. Respirology (2009) 0.76
Why is Acinetobacter baumannii a problem for critically ill patients? Intensive Care Med (2015) 0.76
Does the presence of antibodies justify the use of antibiotics in exacerbations of chronic bronchitis? Am J Respir Crit Care Med (2004) 0.75
The Barcelona Declaration from the World Alliance against Antibiotic Resistance: engagement of intensivists. Crit Care (2012) 0.75
Response. Chest (2014) 0.75
What is the prognosis for using the pneumonia severity index to make site-of-care decisions in community-acquired pneumonia? Chest (2003) 0.75
Distinguishing chemical pneumonitis from bacterial aspiration: still a clinical determination. Crit Care Med (2011) 0.75
Can one plus one ever equal three in the antibiotic therapy of sepsis? Crit Care Med (2010) 0.75
Managing ventilator complications in a "VACuum" of data. Chest (2015) 0.75
Fighting vampires and ventilator-associated pneumonia: is silver the magic bullet? Chest (2010) 0.75
[Argentine consensus for non-invasive ventilation]. Medicina (B Aires) (2006) 0.75
Acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med (2002) 0.75
How do we achieve adequate therapy for severe infection? Crit Care Med (2003) 0.75
Preparing for the unexpected: lessons learned about respiratory infection from the Japanese tsunami of 2011. Chest (2013) 0.75
Ventilator-associated pneumonia prevention: response to Silvestri et al. Intensive Care Med (2015) 0.75
The road forward in the management of Acinetobacter infections in the ICU. Intensive Care Med (2015) 0.75
Year in review 2012: Critical Care--respiratory infections. Crit Care (2013) 0.75
Community-Acquired Pneumonia. Ann Intern Med (2015) 0.75
Decline of outpatient asthma management in Argentina. Respirology (2008) 0.75